Study to assess the safety, tolerability and pharmacokinetics of AZD5055 in Japanese and Chinese healthy volunteers..

Trial Identifier:	D8960C00005
Sponsor:	AstraZeneca
NCTID::	NCT05955183
Start Date:	July 2023
Primary Completion Date:	December 2023
Study Completion Date:	December 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Japanese Translation
	Simplified Chinese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.